In a strategic maneuver designed to cement its dominance in the burgeoning home-based healthcare sector, Cardinal Health has announced the simultaneous acquisition of Strive Medical and AdaptHealth’s diabetes business. The deal, valued at a combined $360 million, represents the latest chapter in the Ohio-based healthcare giant’s aggressive expansion into direct-to-patient medical supply services. By integrating these specialized entities, Cardinal Health aims to scale its "at-home" solutions portfolio, positioning itself as the primary infrastructure provider for the nation’s rapidly growing "hospital-at-home" and chronic care management models.
The Core Transaction: Strategic Consolidation
The dual acquisition is not merely a purchase of assets; it is a calculated effort to deepen Cardinal Health’s footprint in two of the most critical therapeutic categories: urology and diabetes management.
Strive Medical, a known entity in the urology supply chain, brings a robust distribution network that complements Cardinal’s existing, albeit massive, logistical framework. Simultaneously, the acquisition of AdaptHealth’s diabetes unit provides a direct infusion of patient volume and clinical infrastructure, building upon the foundations laid by Cardinal’s 2025 purchase of Advanced Diabetes Supply (ADS).
For Cardinal Health, the "at-home" segment is no longer a peripheral service; it is a cornerstone of their long-term growth strategy. By shifting the delivery of medical care from traditional clinical settings to the patient’s home, the company is capitalizing on a post-pandemic shift in healthcare delivery that emphasizes patient comfort, cost-efficiency, and improved chronic disease management.
Chronology of Expansion: A Pattern of Intent
Cardinal Health’s recent activity reveals a company moving with high velocity to consolidate the fragmented home-care market. The current acquisitions are the culmination of a rigorous 18-month expansion period characterized by a series of high-profile buyouts.
- April 2025: Cardinal Health signals its intent to lead in the diabetes care market with the acquisition of Advanced Diabetes Supply (ADS). This move proved successful, allowing the company to integrate complex pharmacy-to-supplier digital workflows.
- April 2025: Simultaneous expansion into urology begins with the acquisitions of Urology America and Potomac Urology.
- August 2025: The company accelerates its urology focus with the massive $1.9 billion buyout of Solaris Health, followed closely by the purchase of Academic Urology & Urogynecology.
- July 2026: Cardinal Health completes the $360 million purchase of Strive Medical and the diabetes unit of AdaptHealth, effectively bridging the gaps between its previous acquisitions to create a unified, high-scale platform.
This timeline demonstrates a clear "land-and-expand" philosophy. By securing large, anchor assets like Solaris Health and ADS, Cardinal established the skeletal structure of its new business unit. The recent acquisitions serve to "flesh out" this structure, providing the necessary density and operational scale to optimize distribution routes and patient outreach.
Supporting Data and Operational Synergy
The financial and operational logic behind these moves is anchored in the success of the ADS integration. Since the ADS acquisition, Cardinal Health has reported significant operational milestones that validate their current trajectory.
According to company reports, the integration of ADS allowed Cardinal to migrate its entire volume onto the "at-home solutions" distribution network. This consolidation was not just logistical; it was transformative for the company’s patient base. The company successfully onboarded nearly 500,000 new customers, a feat that would have taken years to achieve through organic growth alone.
Furthermore, the launch of the "ContinuCare Pathway"—a pharmacy-to-supplier digital referral program—has streamlined the patient journey. By digitizing the referral process, Cardinal has reduced friction between healthcare providers and the supply chain, ensuring that patients receive their medical supplies with minimal interruption. The current acquisitions of Strive and AdaptHealth are expected to provide the volume necessary to further socialize and scale these digital tools, driving down the per-unit cost of delivery while increasing patient retention rates.
Perspectives from Leadership
The leadership at Cardinal Health views these acquisitions as a natural evolution of their business model. CEO Jason Hollar emphasized that the deals are rooted in the pursuit of synergy, aiming to leverage the infrastructure built over the past two years to create an "enterprise-wide" solution.
"These strategic transactions build on the synergies created by our recent investments in home care," Hollar stated. "As a natural extension of our at-home solutions growth strategy, they expand our enterprise-wide depth and breadth across important therapeutic categories like diabetes management and urology, further strengthening our leadership in a highly dynamic industry."
Rob Schlissberg, President of Cardinal’s At-Home Solutions business, echoed this sentiment, focusing on the operational execution that has enabled this growth. "Our significant operational achievements in FY26 position us to continue building the country’s leading platform to deliver simplified, innovative, and high-quality care in the home, both organically and through acquisition," Schlissberg noted. His comments underscore a focus on "simplified care," implying that Cardinal’s ultimate value proposition is the reduction of complexity for patients navigating chronic conditions.
Implications for the Healthcare Market
The broader implications of this $360 million investment are profound. For the healthcare industry, Cardinal Health’s strategy represents a significant move toward the corporatization and streamlining of home-based care.
1. Market Consolidation
The home-care market has historically been fragmented, comprised of hundreds of regional suppliers and local clinics. Cardinal’s move to consolidate these players under one umbrella suggests a future where a few large-scale entities dominate the supply chain. This could lead to increased standardization of care but may also raise questions about competition and pricing power in the long term.
2. The Rise of "Hospital-at-Home"
The "hospital-at-home" model is increasingly viewed as a solution to hospital overcrowding and the rising costs of traditional inpatient care. By providing the supplies and the logistical backbone for these programs, Cardinal is positioning itself as an essential partner for health systems looking to transition patients out of the hospital sooner. This is not just a distribution play; it is a clinical services play.
3. Technological Integration
The success of the ContinuCare Pathway indicates that the future of medical supply is digital. As Cardinal continues to acquire companies, the ability to integrate disparate IT systems and patient databases will be the true test of their success. If they can successfully merge the digital workflows of Strive Medical and the AdaptHealth unit with their own existing platforms, they will create a seamless digital ecosystem that is difficult for smaller, less-resourced competitors to replicate.
4. Patient-Centric Care
Ultimately, the shift toward home-based care is driven by patient preference. As populations age and the prevalence of chronic diseases like diabetes increases, the demand for care that does not require frequent travel to a clinic will grow. Cardinal’s strategy aligns with these demographic shifts, potentially setting a new standard for how medical supplies are delivered, managed, and monitored.
Conclusion: A High-Stakes Bet on the Future of Care
Cardinal Health’s latest $360 million investment is a definitive signal that the company is fully committed to the home-care revolution. By layering new acquisitions onto the existing successes of its urology and diabetes divisions, the company is building a defensive moat of scale and operational efficiency.
While the challenges of integration remain—specifically in the areas of staff retention, cultural alignment of newly acquired firms, and the ongoing maintenance of digital platforms—Cardinal’s leadership appears confident that their current trajectory is the correct one. As the company looks beyond FY26, the success of these acquisitions will likely serve as the benchmark for how traditional medical distributors must evolve to survive in an era of decentralized, patient-centric healthcare.
The strategy is clear: Cardinal Health is no longer content to simply deliver supplies to hospitals; they intend to deliver the hospital to the patient.
About the Author
